Baillie Gifford's Strategic Reduction in Alnylam Pharmaceuticals Holdings
On June 1, 2024, Baillie Gifford (Trades, Portfolio) executed a significant transaction involving the sale of 590,921 shares of Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), ...
GuruFocus.com via Yahoo
5 days ago